Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Psoriasis: HELP
Paul Peter Tak
Based on 40 articles published since 2008
||||
Expertise Level
The expertise of Paul Peter Tak ranks in the
  • Top 0.48%
  • ... of 37,573 published authors worldwide on Psoriasis
  • ... from 2008 through 2019
  • ... based on contributions to 40 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Tak, P   ·   Tak, Paul Peter   ·   Tak, P P   ·   Tak, Paul-Peter   ·   Tak, Paul-P   ·   Tak, Paul P
Work Locations
Details
Most likely:    University of Amsterdam      
2018
  • Department of Internal Medicine, Prince Mshiyeni Memorial Hospital and School of Clinical Medicine, College of Health Sciences, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands. · School of Laboratory Medicine and Medical Sciences, Discipline of Medical Biochemistry and Chemical Pathology, University of KwaZulu-Natal, George Campbell Building - South Entrance, 3rd Floor, King George V Avenue, Howard College Campus, Durban, 4001, South Africa. · School of Laboratory Medicine and Medical Sciences, Discipline of Medical Biochemistry and Chemical Pathology, University of KwaZulu-Natal, George Campbell Building - South Entrance, 3rd Floor, King George V Avenue, Howard College Campus, Durban, 4001, South Africa. · Pubmed 29587639
2017
  • Department of Clinical Immunology and Rheumatology, University of Amsterdam, Amsterdam, The Netherlands. · Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; and. · Department of Immunology, Imperial College London, Hammersmith Campus, London, United Kingdom. · Pubmed 27733582
2016
  • Division of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center/University of Amsterdam, Amsterdam, the Netherlands, · Department of Experimental Immunology, Academic Medical Center/University of Amsterdam, the Netherlands. · Division of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center/University of Amsterdam, Amsterdam, the Netherlands. · Inserm, Inserm U1151, Institut Necker Enfants Malades, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Division of Vascular Medicine, Academic Medical Center/University of Amsterdam, Amsterdam, the Netherlands. · Pubmed 27616146
  • School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, Ireland. · Department of Rheumatology, St Vincent's University Hospital, Elm Park, Dublin, Ireland. · Northern Ireland Centre for Stratified Medicine, University of Ulster, C-TRIC, Londonderry, UK. · Department of Clinical Immunology and Rheumatology, F4-105, Academic Medical Centre/University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 26108918
  • UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland. · UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland UCD School of Mathematical Sciences, University College Dublin, Dublin, Ireland. · UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland Department of Rheumatology, St. Vincent's University Hospital Dublin, Dublin, Ireland. · Department of Clinical Immunology/Rheumatology, Academic Medical Centre/University of Amsterdam, Amsterdam, Netherlands. · Pubmed 25187158
2015
  • Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands. · Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Cambridge, UK. · Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Research and Development, CSL Limited, Parkville, Victoria, Australia. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Stevenage, UK University of Cambridge, Cambridge, UK. · Pubmed 24936585
  • Certificate in Rheumatology (SA), Prince Mshiyeni Memorial Hospital, Nelson R. Mandela School of Medicine, University of KwaZulu Natal, Durban, South Africa, and the Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, the Netherlands; · Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, the Netherlands. · Pubmed 25554810
2011
  • Department of Medicine, Division of Clinical Immunology and Rheumatology F4-105, Academic Medical Center/University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands. · Pubmed 21624184
2017
  • Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; · Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · GlaxoSmithKline, Cambridge, United Kingdom. · GlaxoSmithKline, Stevenage, United Kingdom. · Department of Rheumatology, Ghent University, Ghent, Belgium; and. · Department of Rheumatology, University of Cambridge, Cambridge, United Kingdom. · Pubmed 28642278
2015
  • From the Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; Arthrogen B.V., Amsterdam; Department of Rheumatology, Atrium Medical Center, Heerlen, the Netherlands.C.J. Aalbers, MD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V.; D.M. Gerlag, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; M.J. Vervoordeldonk, PhD, Arthrogen B.V.; P.P. Tak, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V., and GlaxoSmithKline, and University of Cambridge; R.B. Landewé, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Department of Rheumatology, Atrium Medical Center. · Pubmed 26178282
  • From the Department of Internal Medicine, Prince Mshiyeni Memorial Hospital, Nelson R. Mandela School of Medicine, University of KwaZulu Natal, Durban, South Africa; and the Division of Clinical Immunology and Rheumatology, European League Against Rheumatism (EULAR) and Federation of Clinical Immunology Societies (FOCIS) Center of Excellence, Academic Medical Center/University of Amsterdam, University of Amsterdam, the Netherlands.A.B. Maharaj, MB, BS (Varanasi), H Dip Int Med(SA), FCP (SA), Certificate in Rheumatology (SA), Department of Internal Medicine, Prince Mshiyeni Memorial Hospital, Nelson R. Mandela School of Medicine, University of KwaZulu Natal, and Division of Clinical Immunology and Rheumatology, EULAR and FOCIS Center of Excellence, Academic Medical Center/University of Amsterdam; J. Govender, BSc (Hons)(UDW), MB, ChB (Medunsa); K. Maharaj, MB, ChB (Natal), FCP (SA); M. Rajkaran, MBChB (Wits), FCP(SA), Department of Internal Medicine, Prince Mshiyeni Memorial Hospital, Nelson R. Mandela School of Medicine, University of KwaZulu Natal; P.P. Tak, MD, PhD (UvA), Division of Clinical Immunology and Rheumatology, EULAR and FOCIS Center of Excellence, Academic Medical Center/University of Amsterdam. · Pubmed 25877500
2013
  • Academic Medical Center/University of Amsterdam, Department of Clinical Immunology and Rheumatology, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Pubmed 23861532
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, , Amsterdam, The Netherlands. · Pubmed 23139265
2012
  • Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 23257348
  • Experimental Immunology, University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 22730375
  • Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 21968742
2011
  • Department of Rheumatology, Jan van Breemen Institute, Amsterdam, The Netherlands. · Pubmed 21503693
2010
  • Division of Clinical Immunology and Rheumatology, F4-218, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 20844595
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, NL-1105 AZ Amsterdam, The Netherlands. · Pubmed 19147618
2009
  • Department of Clinical Immunology and Rheumatology, University of Amsterdam, the Netherlands. · Pubmed 19767659
  • University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 19877042
  • Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 19333931
  • Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 19333923
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 18647851
Probable:    University of Cambridge      
2015
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. Electronic address: · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of rheumatology, Flevoziekenhuis, Hospitaalweg 1, 1315 RA Almere, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of Rheumatology, Atrium Medical Center, Postbus 4446, 6401 CX Heerlen, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands; GlaxoSmithKline, Stevenage, UK; University of Cambridge, Cambridge, UK; Ghent University, Ghent, Belgium. · Pubmed 26188879
  • Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands. · Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Cambridge, UK. · Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Research and Development, CSL Limited, Parkville, Victoria, Australia. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Stevenage, UK University of Cambridge, Cambridge, UK. · Pubmed 24936585
2017
  • Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; · Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · GlaxoSmithKline, Cambridge, United Kingdom. · GlaxoSmithKline, Stevenage, United Kingdom. · Department of Rheumatology, Ghent University, Ghent, Belgium; and. · Department of Rheumatology, University of Cambridge, Cambridge, United Kingdom. · Pubmed 28642278
2015
  • From the Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; Arthrogen B.V., Amsterdam; Department of Rheumatology, Atrium Medical Center, Heerlen, the Netherlands.C.J. Aalbers, MD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V.; D.M. Gerlag, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; M.J. Vervoordeldonk, PhD, Arthrogen B.V.; P.P. Tak, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V., and GlaxoSmithKline, and University of Cambridge; R.B. Landewé, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Department of Rheumatology, Atrium Medical Center. · Pubmed 26178282
Probable:    GlaxoSmithKline      
2015
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. Electronic address: · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of rheumatology, Flevoziekenhuis, Hospitaalweg 1, 1315 RA Almere, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of Rheumatology, Atrium Medical Center, Postbus 4446, 6401 CX Heerlen, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands; GlaxoSmithKline, Stevenage, UK; University of Cambridge, Cambridge, UK; Ghent University, Ghent, Belgium. · Pubmed 26188879
  • Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands. · Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Cambridge, UK. · Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Research and Development, CSL Limited, Parkville, Victoria, Australia. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Stevenage, UK University of Cambridge, Cambridge, UK. · Pubmed 24936585
2017
  • Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; · Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · GlaxoSmithKline, Cambridge, United Kingdom. · GlaxoSmithKline, Stevenage, United Kingdom. · Department of Rheumatology, Ghent University, Ghent, Belgium; and. · Department of Rheumatology, University of Cambridge, Cambridge, United Kingdom. · Pubmed 28642278
2015
  • From the Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; Arthrogen B.V., Amsterdam; Department of Rheumatology, Atrium Medical Center, Heerlen, the Netherlands.C.J. Aalbers, MD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V.; D.M. Gerlag, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; M.J. Vervoordeldonk, PhD, Arthrogen B.V.; P.P. Tak, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V., and GlaxoSmithKline, and University of Cambridge; R.B. Landewé, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Department of Rheumatology, Atrium Medical Center. · Pubmed 26178282
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 40 total) written by Paul Peter Tak about Psoriasis:

  • MiR-146a G/C rs2910164 variation in South African Indian and Caucasian patients with psoriatic arthritis. 2018
  • Rheumatoid arthritis and psoriatic arthritis synovial fluids stimulate prolactin production by macrophages. 2017
  • Synovial IL-21/TNF-producing CD4 2017
  • The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation. 2016
  • Reduced CLEC9A expression in synovial tissue of psoriatic arthritis patients after adalimumab therapy. 2016
  • A clinically based protein discovery strategy to identify potential biomarkers of response to anti-TNF-α treatment of psoriatic arthritis. 2016
  • Discovery and confirmation of a protein biomarker panel with potential to predict response to biological therapy in psoriatic arthritis. 2016
  • Intra-articular etanercept treatment in inflammatory arthritis: A randomized double-blind placebo-controlled proof of mechanism clinical trial validating TNF as a potential therapeutic target for local treatment. 2015
  • Single-joint Assessment for the Evaluation of Intraarticular Treatment: Responsiveness and Discrimination of the Composite Change Index. 2015
  • Summary of Sensitivity and Specificity for Psoriatic Arthritis in a South African Cohort according to Classification Criteria. 2015
Show List of Full Article Records
Google Searches

Learn more about Paul Peter Tak using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Amsterdam
University of Cambridge
GlaxoSmithKline
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Amsterdam
2018
  • Department of Internal Medicine, Prince Mshiyeni Memorial Hospital and School of Clinical Medicine, College of Health Sciences, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands. · School of Laboratory Medicine and Medical Sciences, Discipline of Medical Biochemistry and Chemical Pathology, University of KwaZulu-Natal, George Campbell Building - South Entrance, 3rd Floor, King George V Avenue, Howard College Campus, Durban, 4001, South Africa. · School of Laboratory Medicine and Medical Sciences, Discipline of Medical Biochemistry and Chemical Pathology, University of KwaZulu-Natal, George Campbell Building - South Entrance, 3rd Floor, King George V Avenue, Howard College Campus, Durban, 4001, South Africa. · Pubmed 29587639
2017
  • Department of Clinical Immunology and Rheumatology, University of Amsterdam, Amsterdam, The Netherlands. · Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; and. · Department of Immunology, Imperial College London, Hammersmith Campus, London, United Kingdom. · Pubmed 27733582
2016
  • Division of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center/University of Amsterdam, Amsterdam, the Netherlands, · Department of Experimental Immunology, Academic Medical Center/University of Amsterdam, the Netherlands. · Division of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center/University of Amsterdam, Amsterdam, the Netherlands. · Inserm, Inserm U1151, Institut Necker Enfants Malades, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Division of Vascular Medicine, Academic Medical Center/University of Amsterdam, Amsterdam, the Netherlands. · Pubmed 27616146
  • School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, Ireland. · Department of Rheumatology, St Vincent's University Hospital, Elm Park, Dublin, Ireland. · Northern Ireland Centre for Stratified Medicine, University of Ulster, C-TRIC, Londonderry, UK. · Department of Clinical Immunology and Rheumatology, F4-105, Academic Medical Centre/University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 26108918
  • UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland. · UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland UCD School of Mathematical Sciences, University College Dublin, Dublin, Ireland. · UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland Department of Rheumatology, St. Vincent's University Hospital Dublin, Dublin, Ireland. · Department of Clinical Immunology/Rheumatology, Academic Medical Centre/University of Amsterdam, Amsterdam, Netherlands. · Pubmed 25187158
2015
  • Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands. · Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Cambridge, UK. · Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Research and Development, CSL Limited, Parkville, Victoria, Australia. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Stevenage, UK University of Cambridge, Cambridge, UK. · Pubmed 24936585
  • Certificate in Rheumatology (SA), Prince Mshiyeni Memorial Hospital, Nelson R. Mandela School of Medicine, University of KwaZulu Natal, Durban, South Africa, and the Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, the Netherlands; · Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, the Netherlands. · Pubmed 25554810
2011
  • Department of Medicine, Division of Clinical Immunology and Rheumatology F4-105, Academic Medical Center/University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands. · Pubmed 21624184
2017
  • Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; · Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · GlaxoSmithKline, Cambridge, United Kingdom. · GlaxoSmithKline, Stevenage, United Kingdom. · Department of Rheumatology, Ghent University, Ghent, Belgium; and. · Department of Rheumatology, University of Cambridge, Cambridge, United Kingdom. · Pubmed 28642278
2015
  • From the Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; Arthrogen B.V., Amsterdam; Department of Rheumatology, Atrium Medical Center, Heerlen, the Netherlands.C.J. Aalbers, MD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V.; D.M. Gerlag, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; M.J. Vervoordeldonk, PhD, Arthrogen B.V.; P.P. Tak, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V., and GlaxoSmithKline, and University of Cambridge; R.B. Landewé, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Department of Rheumatology, Atrium Medical Center. · Pubmed 26178282
  • From the Department of Internal Medicine, Prince Mshiyeni Memorial Hospital, Nelson R. Mandela School of Medicine, University of KwaZulu Natal, Durban, South Africa; and the Division of Clinical Immunology and Rheumatology, European League Against Rheumatism (EULAR) and Federation of Clinical Immunology Societies (FOCIS) Center of Excellence, Academic Medical Center/University of Amsterdam, University of Amsterdam, the Netherlands.A.B. Maharaj, MB, BS (Varanasi), H Dip Int Med(SA), FCP (SA), Certificate in Rheumatology (SA), Department of Internal Medicine, Prince Mshiyeni Memorial Hospital, Nelson R. Mandela School of Medicine, University of KwaZulu Natal, and Division of Clinical Immunology and Rheumatology, EULAR and FOCIS Center of Excellence, Academic Medical Center/University of Amsterdam; J. Govender, BSc (Hons)(UDW), MB, ChB (Medunsa); K. Maharaj, MB, ChB (Natal), FCP (SA); M. Rajkaran, MBChB (Wits), FCP(SA), Department of Internal Medicine, Prince Mshiyeni Memorial Hospital, Nelson R. Mandela School of Medicine, University of KwaZulu Natal; P.P. Tak, MD, PhD (UvA), Division of Clinical Immunology and Rheumatology, EULAR and FOCIS Center of Excellence, Academic Medical Center/University of Amsterdam. · Pubmed 25877500
2013
  • Academic Medical Center/University of Amsterdam, Department of Clinical Immunology and Rheumatology, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Pubmed 23861532
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, , Amsterdam, The Netherlands. · Pubmed 23139265
2012
  • Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 23257348
  • Experimental Immunology, University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 22730375
  • Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 21968742
2011
  • Department of Rheumatology, Jan van Breemen Institute, Amsterdam, The Netherlands. · Pubmed 21503693
2010
  • Division of Clinical Immunology and Rheumatology, F4-218, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 20844595
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, NL-1105 AZ Amsterdam, The Netherlands. · Pubmed 19147618
2009
  • Department of Clinical Immunology and Rheumatology, University of Amsterdam, the Netherlands. · Pubmed 19767659
  • University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 19877042
  • Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 19333931
  • Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 19333923
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 18647851
Unspecified
2016
  • Clinical Immunology and Rheumatology Department Experimental Immunology Department. · Dermatology Department, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Clinical Immunology and Rheumatology Department. · Clinical Immunology and Rheumatology Department Experimental Immunology Department · Pubmed 27179104
University of Cambridge
2015
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. Electronic address: · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of rheumatology, Flevoziekenhuis, Hospitaalweg 1, 1315 RA Almere, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of Rheumatology, Atrium Medical Center, Postbus 4446, 6401 CX Heerlen, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands; GlaxoSmithKline, Stevenage, UK; University of Cambridge, Cambridge, UK; Ghent University, Ghent, Belgium. · Pubmed 26188879
  • Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands. · Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Cambridge, UK. · Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Research and Development, CSL Limited, Parkville, Victoria, Australia. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Stevenage, UK University of Cambridge, Cambridge, UK. · Pubmed 24936585
2017
  • Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; · Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · GlaxoSmithKline, Cambridge, United Kingdom. · GlaxoSmithKline, Stevenage, United Kingdom. · Department of Rheumatology, Ghent University, Ghent, Belgium; and. · Department of Rheumatology, University of Cambridge, Cambridge, United Kingdom. · Pubmed 28642278
2015
  • From the Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; Arthrogen B.V., Amsterdam; Department of Rheumatology, Atrium Medical Center, Heerlen, the Netherlands.C.J. Aalbers, MD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V.; D.M. Gerlag, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; M.J. Vervoordeldonk, PhD, Arthrogen B.V.; P.P. Tak, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V., and GlaxoSmithKline, and University of Cambridge; R.B. Landewé, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Department of Rheumatology, Atrium Medical Center. · Pubmed 26178282
GlaxoSmithKline
2015
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. Electronic address: · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of rheumatology, Flevoziekenhuis, Hospitaalweg 1, 1315 RA Almere, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of Rheumatology, Atrium Medical Center, Postbus 4446, 6401 CX Heerlen, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands; GlaxoSmithKline, Stevenage, UK; University of Cambridge, Cambridge, UK; Ghent University, Ghent, Belgium. · Pubmed 26188879
  • Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands. · Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Cambridge, UK. · Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Research and Development, CSL Limited, Parkville, Victoria, Australia. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Stevenage, UK University of Cambridge, Cambridge, UK. · Pubmed 24936585
2017
  • Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; · Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · GlaxoSmithKline, Cambridge, United Kingdom. · GlaxoSmithKline, Stevenage, United Kingdom. · Department of Rheumatology, Ghent University, Ghent, Belgium; and. · Department of Rheumatology, University of Cambridge, Cambridge, United Kingdom. · Pubmed 28642278
2015
  • From the Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; Arthrogen B.V., Amsterdam; Department of Rheumatology, Atrium Medical Center, Heerlen, the Netherlands.C.J. Aalbers, MD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V.; D.M. Gerlag, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; M.J. Vervoordeldonk, PhD, Arthrogen B.V.; P.P. Tak, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V., and GlaxoSmithKline, and University of Cambridge; R.B. Landewé, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Department of Rheumatology, Atrium Medical Center. · Pubmed 26178282
University of Ghent
2015
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. Electronic address: · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of rheumatology, Flevoziekenhuis, Hospitaalweg 1, 1315 RA Almere, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of Rheumatology, Atrium Medical Center, Postbus 4446, 6401 CX Heerlen, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands; GlaxoSmithKline, Stevenage, UK; University of Cambridge, Cambridge, UK; Ghent University, Ghent, Belgium. · Pubmed 26188879
2017
  • Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; · Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · GlaxoSmithKline, Cambridge, United Kingdom. · GlaxoSmithKline, Stevenage, United Kingdom. · Department of Rheumatology, Ghent University, Ghent, Belgium; and. · Department of Rheumatology, University of Cambridge, Cambridge, United Kingdom. · Pubmed 28642278
13 Other Locations Show
Yearly article counts 012452365480
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.